HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fatty Liver

Lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of TRIGLYCERIDES, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of FATTY ACIDS.
Also Known As:
Liver Steatosis; Steatohepatitis; Steatosis of Liver; Visceral Steatosis; Liver Steatoses; Liver, Fatty; Steatohepatitides; Steatoses, Liver; Steatoses, Visceral; Steatosis, Liver; Steatosis, Visceral; Visceral Steatoses
Networked: 12465 relevant articles (857 outcomes, 1494 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. Insulin Resistance
2. Obesity
3. Non-alcoholic Fatty Liver Disease
4. Fibrosis (Cirrhosis)
5. Inflammation (Inflammations)

Experts

1. Valenti, Luca: 35 articles (12/2021 - 02/2002)
2. Farrell, Geoffrey C: 31 articles (01/2022 - 01/2002)
3. Yu, Jun: 30 articles (01/2022 - 04/2006)
4. Trauner, Michael: 28 articles (11/2022 - 02/2009)
5. Gao, Bin: 28 articles (01/2021 - 07/2003)
6. Videla, Luis A: 26 articles (01/2022 - 03/2004)
7. McClain, Craig J: 26 articles (12/2021 - 06/2003)
8. Sanyal, Arun J: 25 articles (11/2022 - 05/2003)
9. Portincasa, Piero: 25 articles (01/2022 - 01/2006)
10. Feldstein, Ariel E: 24 articles (01/2022 - 09/2005)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Fatty Liver:
1. Glucose (Dextrose)FDA LinkGeneric
2. LipidsIBA
3. CholesterolIBA
4. Triglycerides (Triacylglycerol)IBA
5. Insulin (Novolin)FDA Link
6. Proteins (Proteins, Gene)FDA Link
7. Fatty Acids (Saturated Fatty Acids)IBA
8. AntioxidantsIBA
9. Ethanol (Ethyl Alcohol)IBA
10. EnzymesIBA

Therapies and Procedures

1. Therapeutics
2. Bariatric Surgery
3. Oral Administration
4. Aftercare (After-Treatment)
5. Glycemic Control